PURPOSE: We have previously identified mouse Tarsh as one of the cellular senescence-related genes and showed the loss of expression of TARSH mRNA in four human lung cancer cell lines. TARSH is a presumptive signal transduction molecule interacting with NESH, which is implicated to have some roles in lung cancer metastasis. METHODS: The amplification of complete ORF-encoding TARSH cDNA was done with reverse transcription-PCR. Northern blotting was carried out using TARSH cDNA probes. To clarify the relationship between TARSH and lung cancer, we quantified TARSH mRNA expression in 15 human lung cancer cell lines and 32 primary non-small cell lung cancers. RESULTS: We first determined the complete ORF-encoding cDNA sequence which is expressed in the human lung. On the Northern hybridization analysis, TARSH was strongly expressed in the human lung. The expression of TARSH mRNA is remarkably downregulated in all the lung cancer cell lines examined. Furthermore, TARSH expression was significantly low in all of the tumor specimens when compared to the expression in corresponding non-neoplastic lung tissue specimens. CONCLUSION: The cancer-associated transcriptional inactivation of TARSH suggests that TARSH could be used as a biomarker for lung cancer development as well as a molecular adjunct for lung carcinogenesis in human.
PURPOSE: We have previously identified mouseTarsh as one of the cellular senescence-related genes and showed the loss of expression of TARSH mRNA in four humanlung cancer cell lines. TARSH is a presumptive signal transduction molecule interacting with NESH, which is implicated to have some roles in lung cancer metastasis. METHODS: The amplification of complete ORF-encoding TARSH cDNA was done with reverse transcription-PCR. Northern blotting was carried out using TARSH cDNA probes. To clarify the relationship between TARSH and lung cancer, we quantified TARSH mRNA expression in 15 humanlung cancer cell lines and 32 primary non-small cell lung cancers. RESULTS: We first determined the complete ORF-encoding cDNA sequence which is expressed in the human lung. On the Northern hybridization analysis, TARSH was strongly expressed in the human lung. The expression of TARSH mRNA is remarkably downregulated in all the lung cancer cell lines examined. Furthermore, TARSH expression was significantly low in all of the tumor specimens when compared to the expression in corresponding non-neoplastic lung tissue specimens. CONCLUSION: The cancer-associated transcriptional inactivation of TARSH suggests that TARSH could be used as a biomarker for lung cancer development as well as a molecular adjunct for lung carcinogenesis in human.
Authors: S Matsuda; C Iriyama; S Yokozaki; Y Ichigotani; N Shirafuji; K Yamaki; T Hayakawa; M Hamaguchi Journal: J Hum Genet Date: 2001 Impact factor: 3.172
Authors: T Takahashi; M M Nau; I Chiba; M J Birrer; R K Rosenberg; M Vinocour; M Levitt; H Pass; A F Gazdar; J D Minna Journal: Science Date: 1989-10-27 Impact factor: 47.728
Authors: Rosa González-Quevedo; Cristina García-Aranda; Alberto Morán; Carmen De Juan; Andrés Sánchez-Pernaute; Antonio Torres; Eduardo Díaz-Rubio; Jose-Luis Balibrea; Manuel Benito; Pilar Iniesta Journal: Int J Oncol Date: 2004-02 Impact factor: 5.650
Authors: Josiah E Radder; Alyssa D Gregory; Adriana S Leme; Michael H Cho; Yanxia Chu; Neil J Kelly; Per Bakke; Amund Gulsvik; Augusto A Litonjua; David Sparrow; Terri H Beaty; James D Crapo; Edwin K Silverman; Yingze Zhang; Annerose Berndt; Steven D Shapiro Journal: Am J Respir Cell Mol Biol Date: 2017-09 Impact factor: 6.914
Authors: Conrad P Hodgkinson; Vinogran Naidoo; Karl G Patti; Jose A Gomez; Jeffrey Schmeckpeper; Zhiping Zhang; Bryce Davis; Richard E Pratt; Maria Mirotsou; Victor J Dzau Journal: Stem Cells Date: 2013-08 Impact factor: 6.277
Authors: Flavia R M Latini; Jefferson P Hemerly; Gisele Oler; Gregory J Riggins; Janete M Cerutti Journal: Endocr Relat Cancer Date: 2008-06-17 Impact factor: 5.678
Authors: Flavia R M Latini; Jefferson P Hemerly; Beatriz C G Freitas; Gisele Oler; Gregory J Riggins; Janete M Cerutti Journal: BMC Cancer Date: 2011-01-11 Impact factor: 4.430
Authors: Yin Xiong; Sichuan Xi; Sudheer Kumar Gara; Jigui Shan; James Gao; Mary Zhang; Vivek Shukla; Ruihong Wang; Chuong D Hoang; Haobin Chen; David S Schrump Journal: JTO Clin Res Rep Date: 2021-05-08